Aaron DeBono
Analyst, CUREator
Aaron joined Brandon Capital in 2022.
Prior to joining Brandon Capital, Aaron was a Business Development Manager at the Murdoch Children’s Research Institute where he managed the commercialisation of projects across the life sciences sector. Prior to his role in business development, Aaron held two postdoctoral positions at Monash Institute of Pharmaceutical Sciences (MIPS) as a medicinal chemist supporting the translation of drug discovery in areas including cancer, infectious disease, myocardial infarction and calcium handling disorders. Aaron has managed research programs for pharma and the US Defense Threat Reduction Agency.
Aaron holds a Bachelor of Medicinal Chemistry (Honours) and a PhD in Medicinal Chemistry.
